147 related articles for article (PubMed ID: 32060721)
41. Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran.
Eshghi P; Cohan N; Lak M; Naderi M; Peyvandi F; Menegatti M; Karimi M
Clin Appl Thromb Hemost; 2012; 18(1):100-3. PubMed ID: 22156982
[TBL] [Abstract][Full Text] [Related]
42. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit.
Mikkola H; Yee VC; Syrjälä M; Seitz R; Egbring R; Petrini P; Ljung R; Ingerslev J; Teller DC; Peltonen L; Palotie A
Blood; 1996 Jan; 87(1):141-51. PubMed ID: 8547636
[TBL] [Abstract][Full Text] [Related]
43. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels.
Mikkola H; Syrjälä M; Rasi V; Vahtera E; Hämäläinen E; Peltonen L; Palotie A
Blood; 1994 Jul; 84(2):517-25. PubMed ID: 8025280
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
45. International registry on factor XIII deficiency: a basis formed mostly on European data.
Ivaskevicius V; Seitz R; Kohler HP; Schroeder V; Muszbek L; Ariens RA; Seifried E; Oldenburg J;
Thromb Haemost; 2007 Jun; 97(6):914-21. PubMed ID: 17549292
[TBL] [Abstract][Full Text] [Related]
46. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
Souri M; Biswas A; Misawa M; Omura H; Ichinose A
Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209
[TBL] [Abstract][Full Text] [Related]
47. Deficiency of factor XIII gene in Chinese: 3 novel mutations.
Duan B; Wang X; Chu H; Hu Y; Huang X; Qu B; Wang H; Wang Z
Int J Hematol; 2003 Oct; 78(3):251-5. PubMed ID: 14604285
[TBL] [Abstract][Full Text] [Related]
48. Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function.
Biswas A; Ivaskevicius V; Thomas A; Varvenne M; Brand B; Rott H; Haussels I; Ruehl H; Scholz U; Klamroth R; Oldenburg J
Ann Hematol; 2014 Oct; 93(10):1665-76. PubMed ID: 24889649
[TBL] [Abstract][Full Text] [Related]
49. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
Onland W; Böing AN; Meijer AB; Schaap MC; Nieuwland R; Haasnoot K; Sturk A; Peters M
Haemophilia; 2005 Sep; 11(5):539-47. PubMed ID: 16128900
[TBL] [Abstract][Full Text] [Related]
50. [An infant with umbilical cord and intracranial hemorrhage--severe factor XIII deficiency].
von der Weid N; Furlan M; Siegenthaler I; Lämmle B
Ther Umsch; 1999 Sep; 56(9):544-6. PubMed ID: 10517131
[TBL] [Abstract][Full Text] [Related]
51. Factor XIII deficiency: an update.
Schroeder V; Kohler HP
Semin Thromb Hemost; 2013 Sep; 39(6):632-41. PubMed ID: 23929307
[TBL] [Abstract][Full Text] [Related]
52. Blood coagulation factor XIII and factor XIII deficiency.
Dorgalaleh A; Rashidpanah J
Blood Rev; 2016 Nov; 30(6):461-475. PubMed ID: 27344554
[TBL] [Abstract][Full Text] [Related]
53. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit.
Lauer P; Metzner HJ; Zettlmeissl G; Li M; Smith AG; Lathe R; Dickneite G
Thromb Haemost; 2002 Dec; 88(6):967-74. PubMed ID: 12529747
[TBL] [Abstract][Full Text] [Related]
54. The burden and management of FXIII deficiency.
de Jager T; Pericleous L; Kokot-Kierepa M; Naderi M; Karimi M
Haemophilia; 2014 Nov; 20(6):733-40. PubMed ID: 25039531
[TBL] [Abstract][Full Text] [Related]
55. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
[TBL] [Abstract][Full Text] [Related]
56. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
Lovejoy AE; Reynolds TC; Visich JE; Butine MD; Young G; Belvedere MA; Blain RC; Pederson SM; Ishak LM; Nugent DJ
Blood; 2006 Jul; 108(1):57-62. PubMed ID: 16556896
[TBL] [Abstract][Full Text] [Related]
57. Identification of novel pathogenic F13A1 mutation and novel NBEAL2 gene missense mutation in a pedigree with hereditary congenital factor XIII deficiency.
Jia S; He Y; Lu M; Liao N; Lei Y; Lauriane N; Liang K; Wei H
Gene; 2019 Jun; 702():143-147. PubMed ID: 30935919
[TBL] [Abstract][Full Text] [Related]
58. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency.
Peyvandi F; Tagliabue L; Menegatti M; Karimi M; Komáromi I; Katona E; Muszbek L; Mannucci PM
Hum Mutat; 2004 Jan; 23(1):98. PubMed ID: 14695539
[TBL] [Abstract][Full Text] [Related]
59. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution.
Morange P; Trigui N; Frère C; Chambost H; Pouymayou C; Uters M; Boucly C; Juhan-Vague I; de Mazancourt P
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):605-6. PubMed ID: 19713833
[TBL] [Abstract][Full Text] [Related]
60. Spontaneous epidural hematoma in a child with inherited factor XIII deficiency.
Farah RA; Al Danaf JZ; Chahinian RA; Braiteh NT; Al Ojaimi NF; Cairo A; Farhat H; Mantoura JR
J Pediatr Hematol Oncol; 2014 Jan; 36(1):62-5. PubMed ID: 23619114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
